Back to KROS

MARSHALL WACE, LLP → KROS

MARSHALL WACE, LLP KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
3
Latest value
$1.3M
Q3 2026
Peak value
$1.3M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$370K
Q3 2026$59K
Q3 2026$1.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.3M110.6K——
Q3 2026$59K5.2K——
Q2 2026$370K34.6K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B